IRLAB THERAPEUTICS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.65 SEK | +0.32% |
|
+0.97% | +108.67% |
| 05-27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
| 05-27 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Equities
- IRLAB A Stock
- Charts IRLAB Therapeutics AB
- Total Return chart
